MSLN and neoplasm: Furthermore, the aberrant expression of MSLN in tumors is closely associated with malignant phenotypes, including tumor cell proliferation, invasion, and resistance to chemotherapy, thereby positioning it as a potential tumor-specific therapeutic target.4